Post Profile

Artificial Pancreas - FDA Provides Options For Designs And Studies

A draft guidance to help artificial pancreas researchers and makers as they create and submit their devices for FDA approval has been issued by the Agency. Artificial pancreases are currently being designed and created for the treatment of diabetes type 1. The draft guidance provides flexible recommendations for the design and testing of devices so that they can still meet regulatory requirements for efficacy and safety.
read more


Related Posts

Top-Quality Clinical Studies For Medical Devices, FDA Seeks Feedback On Proposed Guidelines

Health : Medical News Today

In order to optimize the standard of clinical studies that support the PMA (premarket approval) submissions for medical devices, the FDA has issued a draft guidance. The FDA (Food and Drug Administration) says its draft guidance aim...

FDA Provides Draft Guidance For "Artificial Pancreas" Development

Diseases & Conditions / Diabetes : JJS Diabetes

The FDA issued a draft guidance this week to outline recommendations for clinical trials that will, someday, lead to the approval of a closed-loop insulin pump -- the "artificial pancreas". An artificial pancreas system is an automa...

FDA Issues Guidance to Companies Seeking Approval for Artificial Pancreas System

Industries / Medical : medGadget

The FDA has issued draft guidance to companies that are looking to submit an Investigational Device Exemption (IDE) or premarket approval (PMA) application for an Artificial Pancreas Device System that would be used by patients at h...

FDA Issues Draft Guidance For Early Version Of An Artificial Pancreas System

Health : Medical News Today

The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States. Type 1 diabetes is a chronic condi...

FDA issues guidance for artificial pancreas

Health : The Chart

The FDA issued draft guidance on Thursday, intended for researchers and device manufactures working to develop and gain FDA approval for an artificial pancreas device system for treating type one diabetes. In June 2011, the FDA prov...


Copyright © 2016 Regator, LLC